Second Round of abstract submission : December 13, 2018 | Welcome Message

Theme : Leading Advancements ,Remedies in the latest projects and empowering the people with dementia

Organizing Committee Members



Science Access invites all the participants from all over the world to attend 2nd International Conference on Alzheimer's and Parkinson's Diseases which will be held during March 04-06, 2019 at London, UK. The conference mainly focuses “Leading Advancements ,Remedies in the latest projects and empowering the people with dementia”.

Dementia is a loss of mental ability severe enough to interfere with normal activities of daily living, lasting more than six months, not present since birth, and not associated with a loss or alteration of consciousness.

Dementia is a group of symptoms caused by the gradual death of brain cells The loss of cognitive abilities that occurs with dementia leads to impairments in memory, reasoning, planning, and behavior. While the overwhelming numbers of people with dementia are elderly, dementia is not an inevitable part of aging; instead, dementia is caused by specific brain diseases. Alzheimer's disease is the most common cause, followed by vascular or multi-infarct dementia.

The prevalence of dementia is difficult to determine, partly because of differences in definition among different studies and partly because there is some normal decline in functional ability with age. The prevalence of dementia roughly doubles for every five years of age beginning at age 60. Dementia affects about 1% of people between ages 60 and 64, 5-8% of all people between ages 65 and 74, up to 20% of those between 75 and 84, and between 30% and 50% of those age 85 and older. About 60% of nursing home patients have dementia. The Alzheimer's Association estimates that in 2007, 5.1 million Americans were living with a diagnosis of an AD. That number expected to grow substantially as the population ages.

The cost of dementia can be considerable. While most people with dementia are retired and are not affected by income losses from their disease, the cost of care often is enormous. Financial burdens include lost wages for family caregivers, medical supplies and drugs, and home modifications to ensure safety. Nursing home care may cost several thousand dollars a month or more. The psychological cost is not as easily quantifiable but can be even more profound. The person with dementia loses control of many of the essential features of his life and personality, and loved ones lose a family member even as they continue to cope with the burdens of increasing dependence and unpredictability

Conference Highlights

  • 200+ Participation (50% Academic: 30% Hospitals: 20% Industry)
  • 9+ Keynote Speakers
  • 30+ Plenary Speakers
  • 3+ Exhibitors
  • 14 Innovative Educational Sessions
  • B2B Meetings
  • Exhibition

Target Audience

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Healthcare professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia
  • Students from Academia in the research of Neurology

Why should you attend?

Alzheimer’s Congress 2019 will give a chance to all partners chipping away at Alzheimer's infection and Dementia to discuss their work. Dementia 2018 will assemble prestigious speakers, important examiners, specialists, neurologists and Dementia analysts from both scholarly community and social insurance industry will consolidate to talk about their perspectives and research. The gathering will be involved sessions by world-class specialists in the field of neurology. In Dementia 2019, global symposiums, B2B gatherings, worldwide workshops will likewise be sorted out to talk about the particular points in the field of Dementia and Neurology.

Science Access Ltd arranges gathering arrangement all around the Globe in 2018. Here we invite you to the 2nd International Conference on Alzheimer's and Parkison's which will be held during March 04-06, 2019 at London,Uk. 

Neurological changes in mind, Alzheimer's sickness Imaging, Disease Mechanisms, Geriatrics and Cognitive Disorder, Path physiology, Brain injury, Care practice and Awareness, Current Research in Alzheimer's and Parkinson's Diseases.

Importance and Scope: -

Dementia is a general term that portrays a gathering of side effects, for example, loss of memory, judgment, dialect, complex engine abilities, and other scholarly capacity caused by the lasting harm or passing of the cerebrum's nerve cells, or neurons.

Dementia, including Alzheimer's infection, is one of the greatest worldwide general wellbeing challenges confronting our era.

Universally, aftereffects of a current meta-investigation recommend that 44 million individuals lived with dementia worldwide in 2010, with numbers anticipated that would twofold at regular intervals, to 65.7 million of every 2030 and 115.4 million out of 2050. In 2010, 58 percent surprisingly with dementia lived in nations with low or center wages, with this extent foreseen to ascend to 63 percent in 2030 and 71 percent in 2050.This number is relied upon to twofold by 2030 and more than triple by 2050 to 115 million.

In the United States alone, specialist’s gauge that upwards of five million individuals age 65 and more established experience the ill effects of Alzheimer's sickness The AD market has a lack of therapeutic options.

  • Which classes of drug dominate the market?
  • What newly approved therapies have entered the market?
  • How do the leading marketed therapies compare clinically?
  • How will the new therapies be positioned in the treatment of AD?
  • How have selected late-stage pipeline therapies performed in clinical trials?
  • The pipeline contains a range of molecule types and molecular targets, including those that are well established in the AD, and novel, first-in-class therapies.
  • Which molecular targets appear most frequently in the pipeline?
  • AD clinical trials have an overall attrition rate of 94%.
  • What are the failure rates for individual Phases of clinical development?
  • How do AD clinical trial characteristics, including failure rate, duration, and size compare against respiratory and industry averages?
  • The AD market is forecast to rise from a value of $5.2 billion in 2014 to $11.3 billion in 2021, at a CAGR of 11.8% across the eight major markets assessed.
  • How much of a role will disease prevalence and new product approvals play in market growth?
  • Will generic competition have a significant impact on the market over the forecast period?
  • There have been 170 licensing deals and 104 co-development deals pertaining to AD products since  2006.
  • Which territories show the most deal activity?
  • What were the trends in deal completion by-product stage of development?
  • What were the conditions of the key licensing or co-development deals to take place in the AD?

Why in LONDON:

London is the biggest city in Britain and in Europe. The City of London is the seat of central government in Britain.

London attracts very large numbers of visitors and tourists. Tourist attractions are mainly in Central London. Plan your day well. London is a big place and if you are not careful you may find yourself spending most of the day travelling.

The most popular and our favourite attractions are: Big Ben, London Eye, Tower of London, River Thames, Buckingham Palace, British Museum, Tower Bridge, Hyde Park, Trafalgar Square, Palace of Westminster, St Paul's Cathedral, Piccadilly Circus, Westminster Abbey, The Shard, National Gallery, London, Oxford Street, London Bridge, Tate Modern, London, Natural History Museum, London, Victoria and Albert Museum, Kensington Palace, Regent's Park, St James's Park, Leicester Square, Kensington Gardens, London Dungeon, The Royal Albert Hall, Brick Lane, London Zoo, Science Museum, London, Monument to the Great Fire of London, Royal Observatory, Greenwich, Shakespeare's Globe, Sea Life London Aquarium, Wimbledon, Churchill War Rooms, Madame Tussauds London, Museum of London, National Maritime Museum, Cutty Sark, National Portrait Gallery, London, Royal Opera House, London, HMS Belfast, Queen's Gallery, Banqueting House, Whitehall, Covent Garden, Soho, Harrods.

The delegates will experience first-hand the City of London. They will also have the opportunity to visit the world-famous places of London. Given excellent transportation which can enable our delegates to visit many places of interest within London with great ease and on their own.

Why attend?

Internatinal Conference on Alzheimer's and Parkinson's Diseases is a one of a kind gathering to unite overall recognized scholastics in the field of neuroscience and neurology, Brain specialists, general wellbeing experts, researchers, scholastic researchers, industry analysts, researchers to trade about best in class research and advances

Point of this gathering is fortifying new thoughts for treatment that will be painful over the range of Neuroscience

A Unique Opportunity for Advertisers and Sponsors at this International occasion

For more points of interest please visit-


  • University College London (UCL) 
  • Imperial College London        
  • King's College London 
  • London School of Economics and Political Science (LSE)
  • Queen Mary, University of London 
  • Royal Holloway, University of London 
  • School of Oriental and African Studies (SOAS) 
  • Birkbeck College, University of London 
  • City University of London
  • Brunel University 

Dementia Related research centers around the Globe

  • Dementia Research Centre - UCL
  • Centre for Dementia - The University of Nottingham
  • Centre for Dementia Studies - BSMS
  • Alzheimer Scotland Dementia Research Centre
  • UK Dementia Research Institute (UK DRI)
  • Centre for Dementia Research - Leeds Beckett University
  • Centre for Ageing and Dementia Research
  • Centre for Ageing Research in the Environment (Singapore)
  • UK Dementia Research Institute
  • Dementia Research Institute - Cardiff University
  • Global funding body on dementia
  • Dementia Discovery Fund
  • Global Dementia | JPND
  • Dementia – Institute of Mental Health

Alzheimer’s association members

Following are some companies in Landon which produce Neurology drugs they are:

  • Pfizer
  • GlaxoSmithKline
  • Solvay of Belgium
  • Fujisawa Pharmaceutical
  • Meiji Seika
  • Janssen Pharmaceutical
  • Lund beck
  • Asahi Kasei Corporation
  • Forest Laboratories
  • Eli Lilly
  • Wyeth Pharmaceuticals
  • Organ on International

Major Associations around the Globe

  • Neuropathy Association
  • The brain & behavior research foundation
  • Alzheimer's Association
  • American Academy of Neurology
  • European Neurological Societies
  • World Federation of Neurology
  • Major Neurological Associations in Italy
  • Hilarescere Foundation in Italy
  • Italian MS society in Italy
  • Southern Clinical Neurological Society
  • ESNR European Society of  Neuroradiology
  • Vision sciences society

Around 500 top universities globally working in the field of Neuroscience

  • Dalhousie University
  • Leiden University- Neither land
  • Temple University the USA
  • University Oklahoma
  • Boston Coll the USA
  • Florida International University
  • University California – Davis
  • University Sheffield
  • University Manchester
  • University of Nottingham
  • Cardiff University
  • University of Toronto Canada
  • Hospitals Associated with Neuroscience Research

All around the globe there are 6000 hospitals working on Neurology

  • Johns Hopkins Hospital
  • World Brain Center Hospital
  • Duke University Hospital
  • Edward Hospital
  • Munson Medical Center


Target Audience

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Psychiatrists
  • Psychologists
  • Neurosurgeons
  • Nutritional Scientists
  • Industrial Experts
  • Lecturers and Students from Academia in the study of Diseases
  • geriatricians
  • Students from Academia in the research of Dementia
  • Specialists

Contact Us

Feel Free To Contact Us

Address   : 2737 Live Oak Street, Huntington Park, CA 90255, USA
Phone No : +1-302-428-9993
Fax           : +1-267-646-2200
Email Id    :


Subscribe Neurology Conference

Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!